Thymoquinone > Inflammation

Thymoquine & Inflammation

Thymoquinone in black seed oil has shown considerable promise as a natural anti-inflammatory agent. Research highlights thymoquinone’s potential to reduce systemic inflammation, making it valuable for managing conditions such as arthritis, metabolic syndrome, and neuroinflammation.

Key Findings
  • Reduces Inflammatory Markers: Thymoquinone has been shown to decrease pro-inflammatory cytokines, aiding in the reduction of systemic inflammation (Kanter et al., Basic & Clinical Pharmacology & Toxicology, 2005).
  • Potential in Arthritis Management: Research suggests thymoquinone may reduce joint inflammation and pain in arthritis by inhibiting inflammatory enzymes and pathways (Al-Nahain et al., BMC Complementary and Alternative Medicine, 2014).
  • Neuroprotective Anti-Inflammatory Effects: Some studies indicate that thymoquinone can reduce neuroinflammation, which may have implications for conditions like Alzheimer's and Parkinson’s disease (Sahak et al., Neuroscience Letters, 2016).
Studies at a Glance
  • Decreases Cytokine Levels: Thymoquinone was found to lower levels of key inflammatory cytokines in a clinical study, reducing markers of inflammation (Kanter et al., Basic & Clinical Pharmacology & Toxicology, 2005)
  • Reduces Arthritis Symptoms: Thymoquinone has demonstrated anti-inflammatory effects in arthritis models, reducing joint pain and swelling (Al-Nahain et al., BMC Complementary and Alternative Medicine, 2014).
  • Neuroinflammatory Reduction: Research shows that thymoquinone can help protect against neuroinflammation, supporting brain health (Sahak et al., Neuroscience Letters, 2016).
Dosage and Suggested Use
  • Clinical Dosage Range: For anti-inflammatory benefits, black seed oil doses range from 500 mg to 2 g per day, depending on individual needs and the condition being addressed.
  • Consultation Recommendation: Consultation with a healthcare provider is recommended to determine the most effective dosage and form for inflammation management.

Subscribe to our newsletter